NCT03263572
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein Expression, +29 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
t(9;22)
Explore clinical trials studying t(9;22). Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
t(9;22) trial results
NCT00390793
- Conditions
- Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein Expression, Blast Crisis, +26 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States